Updated RINGSIDE Phase 2 Results Featured in Poster Discussion Session at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Data show enhanced anti-tumor activity of AL102 over time Registration-enabling Phase 3 segment of RINGSIDE…
News
Updated RINGSIDE Phase 2 Results Featured in Poster Discussion Session at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Data show enhanced anti-tumor activity of AL102 over time Registration-enabling Phase 3 segment of RINGSIDE…
NovelMed Phase I Clinical Trial Shows Inhibition of the Alternative Pathway and Preservation of the Classical Pathway – A Long-Acting Anti-Properdin Monoclonal Antibody NM3086 for PNH Patients
Phase I Clinical Trial in healthy subjects shows that NM3086 was safe and well tolerated…
NovelMed Phase I Clinical Trial Shows Inhibition of the Alternative Pathway and Preservation of the Classical Pathway – A Long-Acting Anti-Properdin Monoclonal Antibody NM3086 for PNH Patients
Phase I Clinical Trial in healthy subjects shows that NM3086 was safe and well tolerated…
Walden Biosciences Announces First Subject Dosed in First-in-Humans Phase 1 Clinical Trial of WAL0921, in Development for Treatment of Chronic Kidney Diseases
Trial to Evaluate Proprietary Human anti-suPAR Monoclonal Antibody for Safety, Pharmacokinetics and Pharmacodynamics in Healthy…
Walden Biosciences Announces First Subject Dosed in First-in-Humans Phase 1 Clinical Trial of WAL0921, in Development for Treatment of Chronic Kidney Diseases
Trial to Evaluate Proprietary Human anti-suPAR Monoclonal Antibody for Safety, Pharmacokinetics and Pharmacodynamics in Healthy…
TG Therapeutics to Participate in the 2023 Jefferies Healthcare Conference
Fireside chat scheduled for Wednesday, June 7, 2023, at 11:30 AM ET NEW YORK, June…
TG Therapeutics to Participate in the 2023 Jefferies Healthcare Conference
Fireside chat scheduled for Wednesday, June 7, 2023, at 11:30 AM ET NEW YORK, June…
Aptose Biosciences Provides Update on Reverse Stock Split
Common Shares to begin trading on adjusted basis June 6 SAN DIEGO and TORONTO, June…
Aptose Biosciences Provides Update on Reverse Stock Split
Common Shares to begin trading on adjusted basis June 6 SAN DIEGO and TORONTO, June…
Chimeric Therapeutics To Attend BIO International Convention
SYDNEY, Australia and NEW YORK, June 05, 2023 (GLOBE NEWSWIRE) — Chimeric Therapeutics (ASX: CHM)…
Chimeric Therapeutics To Attend BIO International Convention
SYDNEY, Australia and NEW YORK, June 05, 2023 (GLOBE NEWSWIRE) — Chimeric Therapeutics (ASX: CHM)…
Ocugen, Inc. Announces Business Advisory Board
MALVERN, Pa., June 05, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ:…
Ocugen, Inc. Announces Business Advisory Board
MALVERN, Pa., June 05, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ:…
Cellebrite Announces Innovative Case-Closing Technology; Raising the Bar for Modern Investigations
Building on established “Collect and Review” Solutions, UFED Ultra brings new level of excellence to digital…
PingCAP Unveils TiDB 7.1, the Latest Advancement In Open Source, Distributed SQL Database Technology
SUNNYVALE, Calif., June 05, 2023 (GLOBE NEWSWIRE) — PingCAP, the innovative developer of leading distributed…
Sensydia Secures $3M NIH Grant to Advance AI-Based Cardiac Assessment Platform
NIH STTR Fast-Track grant helps propel Sensydia’s non-invasive CPS platform building on recent funding round…
Improving Fleet Efficiency and Increasing Drive Time: Eleos and PrePass Use OpenCab to Streamline Commercial Vehicle Operations
Greenville, South Carolina–(Newsfile Corp. – June 5, 2023) – Eleos Technologies, a leading provider of…
SugarCRM and sales-i Announce Strategic Partnership to Provide Predictive B2B Sales Intelligence, Unlocking Newfound Revenue Opportunities
The Collaboration Supercharges B2B Sales Performance in the Manufacturing, Wholesale, and Distribution Sectors via Artificial…
Altoida Appoints Marc Jones as Chief Executive Officer
WASHINGTON–(BUSINESS WIRE)–#AR—Altoida, Inc, a pioneer in developing digital biomarkers of neurological disease using augmented reality…